"" OSR Health Delisted from Nasdaq After Bid Price Failure
OSR Health Inc. (NASDAQ:OSRH) will have its stock and warrants suspended from trading on The Nasdaq Capital Market at the opening of business on August 26, 2026, following a delisting determination from Nasdaq. The company had failed to meet the exchange's minimum bid price requirement of $1.00.
The delisting determination was made after OSR Health received an initial 180-day compliance period through March 4, 2026, and an additional 180-day period through August 31, 2026. However, the company's share price fell below the required minimum on August 18, 2026.
According to CEO Peter Hwang, the company came within 16 cents of compliance and is requesting a hearing before the Nasdaq Independent Hearings Panel to appeal the determination. However, there is no assurance that the panel will grant the company's request for continued listing or reinstatement of trading.
Trading Suspension Details
- Date: August 26, 2026
- Company: OSR Health Inc. (NASDAQ:OSRH)
- Listing: The Nasdaq Capital Market
- Reason: Minimum bid price compliance failure
- Share Price: $0.84 (intraday high on August 18, 2026)
- Public Float: Approximately 18.5 million shares
- Trading Volume: Approximately 145 million shares on August 18, 2026, and 370 million shares on August 17, 2026
- Hearing Request: OSR Health plans to request a hearing before the Nasdaq Independent Hearings Panel to appeal the determination.